Court Extends HITIQ Listed Options Quotation Period to December 2025
HITIQ Limited secured a Federal Court order extending the quotation period for its HIQOA listed options on the ASX, resolving a regulatory timing issue and validating the delayed admission.
- Federal Court extends quotation period to 24 December 2025
- Court validates issue of 22.3 million listed options despite delay
- Orders require notification to ASIC, ASX, and option holders
- 28-day window for challenges to court orders
- No costs awarded in the proceeding
Federal Court Grants Quotation Extension for Listed Options
HITIQ Limited (ASX:HIQ) has won a crucial legal victory with the Federal Court of Australia approving an extension for the admission to quotation of its HIQOA listed options on the ASX. The court’s orders, dated 16 June 2026, effectively extend the quotation period retroactively to 24 December 2025, addressing the delay in listing the 16.1 million Underwriter Options and 6.2 million Broker Options issued under the company’s May 2025 prospectus.
This extension means the issue of these 22.3 million options is not invalidated despite missing the original ASX quotation deadline stipulated under the Corporations Act. The court’s validation removes a potential cloud over the securities’ legitimacy, reassuring investors and market participants of their standing.
Compliance and Notification Requirements
Following the orders, HITIQ must promptly serve sealed copies on the Australian Securities and Investments Commission, ASX Limited, and all recipients of the Underwriter and Broker Options. Additionally, the company is required to publish the court orders on the ASX Market Announcements Platform, ensuring transparency and regulatory compliance.
The court also granted a 28-day period during which any party claiming substantial injustice from the orders may apply to vary or discharge them, introducing a limited window for potential challenges. The absence of any costs order means each party bears its own legal expenses.
Implications for HITIQ’s Capital Structure and Market Activity
While the announcement does not detail the reasons behind the initial delay in quotation, resolving this legal hurdle clears the way for HITIQ to move forward with its capital management plans involving these listed options. The options were issued as part of secondary offers to support the company’s funding and strategic initiatives.
HITIQ’s recent trajectory includes scaling its PROTEQT™ concussion management system nationally and internationally, supported by government grants and loan facilities, as the company pushes to commercialise its athlete safety technology. The court’s decision stabilises a key element of its capital structure amid these growth efforts.
Bottom Line?
The court’s validation of HITIQ’s listed options settles a regulatory snag, but the 28-day challenge period leaves a brief window of uncertainty for option holders and the company’s funding plans.
Questions in the middle?
- What caused the initial delay in the ASX quotation of HITIQ’s listed options?
- Could any party challenge the court orders within the 28-day window, and what impact might that have?
- How will this legal resolution influence HITIQ’s upcoming capital management or fundraising activities?
